Singapore markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
149.62-0.62 (-0.41%)
At close: 04:00PM EDT
149.62 0.00 (0.00%)
After hours: 06:26PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-332,076
-440,242
-1,131,156
-852,824
-858,281
-
Depreciation & amortisation
96,438
97,031
85,550
89,694
74,435
-
Stock-based compensation
227,080
221,680
230,649
165,717
139,873
-
Change in working capital
-24,402
10,759
-35,553
-162,823
-12,701
-
Accounts receivable
-106,682
-87,939
-45,597
-101,799
-56,236
-
Inventory
18,792
18,367
-34,136
-26,415
-35,426
-
Accounts payable
157,950
80,840
191,769
88,240
143,732
-
Other working capital
127,823
41,945
-613,333
-718,065
-685,322
-
Other non-cash items
114,365
106,987
104,679
135,805
95,755
-
Net cash provided by operating activities
189,116
104,156
-541,274
-641,693
-614,961
-
Cash flows from investing activities
Investments in property, plant and equipment
-61,293
-62,211
-72,059
-76,372
-70,361
-
Purchases of investments
-1,807,870
-1,823,501
-1,976,961
-1,656,114
-2,025,626
-
Sales/maturities of investments
1,545,848
1,553,800
2,231,568
1,463,550
1,691,669
-
Other investing activities
-
-4,438
-13,194
-4,364
-31,200
-
Net cash used for investing activities
-327,753
-336,350
169,354
-273,300
-435,518
-
Cash flows from financing activities
Debt repayment
-
-
-762,107
0
0
-30,000
Common stock issued
-
-
0
0
99,498
781,900
Other financing activities
23,719
24,667
-87,611
500,850
494,997
-
Net cash used provided by (used for) financing activities
154,671
172,131
425,753
1,247,118
994,979
-
Net change in cash
10,308
-53,672
46,403
323,107
-50,582
-
Cash at beginning of period
674,411
868,556
822,153
499,046
549,628
-
Cash at end of period
690,445
814,884
868,556
822,153
499,046
-
Free cash flow
Operating cash flow
189,116
104,156
-541,274
-641,693
-614,961
-
Capital expenditure
-61,293
-62,211
-72,059
-76,372
-70,361
-
Free cash flow
127,823
41,945
-613,333
-718,065
-685,322
-